Dr Philipp Daim: key facts
- Kind of voice
- Academic
- Role
- review author, University of Minnesota
- Quoted on
- Cancer
- Tracked press citations
- 1
- Most recently quoted
- 10 Sept 2026
“With new data now available, we can now say with moderate certainty that PSA screening reduces prostate cancer deaths in men with a sufficient life expectancy. This suggests that for the right patient – someone who is well-informed, has a good life expectancy, and understands the full implications of screening – there is now a reasonable evidence base to support a conversation about PSA screening.”
Where Dr Philipp Daim has been quoted
- Cochrane reviewers conclude PSA testing reduces deaths from prostate cancerpulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.